Houguang Zhou Selected Research

Proteins (Proteins, Gene)

1/2017	Transient upregulation of Nav1.6 expression in the genu of corpus callosum following middle cerebral artery occlusion in the rats.
1/2015	HCdc14A is involved in cell cycle regulation of human brain vascular endothelial cells following injury induced by high glucose, free fatty acids and hypoxia.
11/2011	RNA interference targeting NRP-1 inhibits human glioma cell proliferation and enhances cell apoptosis.
1/2009	The protein therapy of kallikrein in cerebral ischemic reperfusion injury.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Houguang Zhou Research Topics

Disease

7	Brain Ischemia (Cerebral Ischemia) 01/2017 - 01/2009
4	Hypoxia (Hypoxemia) 01/2015 - 04/2011
4	Acidosis 11/2012 - 10/2009
3	Cerebral Hemorrhage 10/2016 - 04/2011
2	Insulin Resistance 01/2019 - 04/2016
2	Atherosclerosis 01/2019 - 08/2015
2	Intracranial Hemorrhages (Intracranial Hemorrhage) 03/2018 - 10/2016
2	Type 2 Diabetes Mellitus (MODY) 04/2016 - 08/2015
2	Ischemia 02/2011 - 10/2009
2	Infarction (Infarctions) 10/2009 - 01/2009
1	Inflammation (Inflammations) 01/2021
1	Cognitive Dysfunction 04/2019
1	Abdominal Obesity 01/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2019
1	Overweight 01/2019
1	Brain Edema (Cerebral Edema) 03/2018
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2017
1	Non-alcoholic Fatty Liver Disease 04/2016
1	Hematoma 03/2016
1	Pathologic Constriction (Stenosis) 08/2015
1	Hyperglycemia 01/2015
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2015
1	Hyperlipidemias (Hyperlipidemia) 01/2015
1	Hypercholesterolemia 01/2015
1	Stroke (Strokes) 01/2015
1	Ischemic Stroke 01/2015
1	Drug-Related Side Effects and Adverse Reactions 01/2015
1	Vascular Diseases (Vascular Disease) 11/2014
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 11/2014
1	Glioma (Gliomas) 11/2011
1	Neoplasms (Cancer) 11/2011
1	Central Nervous System Diseases (CNS Diseases) 12/2009
1	Reperfusion Injury 01/2009
1	Nervous System Diseases (Neurological Disorders) 01/2009

Drug/Important Bio-Agent (IBA)

5	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 10/2009
4	Glutamic Acid (Glutamate)FDA Link 03/2018 - 12/2009
4	Proteins (Proteins, Gene)FDA Link 01/2017 - 01/2009
4	Tissue Kallikreins (Tissue Kallikrein)IBA 11/2012 - 10/2009
3	C-Reactive ProteinIBA 01/2021 - 08/2015
3	Nonesterified Fatty Acids (NEFA)IBA 01/2015 - 01/2015
2	Biomarkers (Surrogate Marker)IBA 04/2019 - 08/2015
2	HDL CholesterolIBA 01/2019 - 08/2015
2	Rosiglitazone (Avandia)FDA Link 03/2018 - 03/2016
2	PPAR gammaIBA 03/2018 - 03/2016
2	OsteoprotegerinIBA 04/2016 - 08/2015
2	Mitogen-Activated Protein KinasesIBA 01/2015 - 11/2011
2	Acid Sensing Ion ChannelsIBA 02/2011 - 10/2009
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	heparanaseIBA 01/2021
1	cathepsin SIBA 01/2019
1	Triglycerides (Triacylglycerol)IBA 01/2019
1	Insulin (Novolin)FDA Link 01/2019
1	Messenger RNA (mRNA)IBA 01/2017
1	Sodium Channels (Sodium Channel)IBA 01/2017
1	Therapeutic UsesIBA 10/2016
1	CholesterolIBA 08/2015
1	HDL LipoproteinsIBA 08/2015
1	Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA 08/2015
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2015
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2015
1	Cyclin BIBA 01/2015
1	Cyclin EIBA 01/2015
1	Caspase 3 (Caspase-3)IBA 01/2015
1	Rosuvastatin Calcium (Crestor)FDA Link 01/2015
1	Cyclin DIBA 01/2015
1	LipidsIBA 01/2015
1	Cytochrome P-450 CYP2C9IBA 01/2015
1	SugarsIBA 11/2014
1	Bradykinin B2 ReceptorIBA 11/2012
1	JNK Mitogen-Activated Protein KinasesIBA 11/2011
1	Small Interfering RNA (siRNA)IBA 11/2011
1	Neuropilin-1IBA 11/2011
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2011
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 11/2011
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 11/2011
1	Serine Proteases (Serine Protease)IBA 02/2011
1	propionic acid (potassium propionate)IBA 12/2009
1	N-Methylaspartate (NMDA)IBA 12/2009
1	AMPA Receptors (AMPA Receptor)IBA 12/2009
1	Bradykinin Receptors (Bradykinin Receptor)IBA 10/2009
1	Oxygen (Dioxygen)IBA 10/2009
1	AntioxidantsIBA 10/2009
1	icatibantIBA 01/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2009
1	Dinoprostone (PGE2)FDA Link 01/2009
1	Neuroprotective AgentsIBA 01/2009
1	Coloring Agents (Dyes)IBA 01/2009
1	Kallikreins (Kallikrein)IBA 01/2009

Therapy/Procedure

6	Therapeutics 03/2018 - 01/2009
2	Minimally Invasive Surgical Procedures 03/2018 - 03/2016
2	Punctures 06/2011 - 04/2011
1	Stem Cell Transplantation 10/2016
1	Craniotomy 06/2011